GenSight Biologics S.A. (EPA:SIGHT)
0.2650
+0.0365 (15.97%)
Apr 24, 2025, 5:35 PM CET
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €29.72 million as of April 24, 2025. Its market cap has decreased by -4.29% in one year.
Market Cap
29.72M
Enterprise Value
46.37M
Revenue
2.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.27
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 29.72M, a decrease of -88.21%. That is a compound annual growth rate of -21.60%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
EssilorLuxottica Société anonyme | 112.94B |
Sanofi | 111.03B |
Sartorius Stedim Biotech | 18.21B |
bioMérieux | 13.41B |
Eurofins Scientific SE | 9.03B |
Ipsen | 7.46B |
Virbac | 2.53B |
emeis Société anonyme | 1.87B |